Single-Dose radiation during breast surgery: a new hope?

NCT ID NCT03121469

Completed Symptom relief Sponsor: Centre Antoine Lacassagne Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tested a device called Papillon +TM that delivers a single dose of radiation directly to the tumor site during breast cancer surgery. 28 women aged 60 and older with early-stage breast cancer took part. The main goal was to see if the technique was feasible and safe, not to measure long-term cancer control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Papillon +TM radiotherapy device
What this could lead to: If successful, this could offer a more convenient way to deliver radiation during breast cancer surgery, potentially reducing the need for follow-up visits.
What could go wrong: This is a very small, early-phase study (28 people) focused on whether the technique is even possible. It is not designed to prove it works better than standard treatment, and long-term safety or effectiveness is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALIZED BREAST CANCER

Contacts and locations

Locations

Centre Antoine Lacassagne

Nice, 06189, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.